PDCD1 and neoplasm: A further PDE model consisting of patient-derived tumor tissues embedded in collagen and termed organotypic tumor spheroids (PDOTS) maintains immune cell composition when cultured in microfluidic chips, and anticipates clinical benefit of PD-1 blockade based on cyto/chemokine release (17, 18).